CHOROIDAL THICKNESS IN PATIENTS WITH DIABETIC RETINOPATHY ANALYZED BY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY
Purpose: This study was designed to examine choroidal thickness in patients with diabetes using spectral-domain optical coherence tomography. Methods: Forty-nine patients (49 eyes) with diabetes and 24 age-matched normal subjects underwent high-definition raster scanning using spectral-domain optic...
Main Authors: | , , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | en_US |
Published: |
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
2014
|
Online Access: | http://hdl.handle.net/1721.1/86410 https://orcid.org/0000-0002-0828-4357 |
_version_ | 1826194851542073344 |
---|---|
author | Regatieri, Caio V. Branchini, Lauren Carmody, Jill Fujimoto, James G. Duker, Jay S. |
author2 | Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science |
author_facet | Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science Regatieri, Caio V. Branchini, Lauren Carmody, Jill Fujimoto, James G. Duker, Jay S. |
author_sort | Regatieri, Caio V. |
collection | MIT |
description | Purpose: This study was designed to examine choroidal thickness in patients with diabetes using spectral-domain optical coherence tomography.
Methods: Forty-nine patients (49 eyes) with diabetes and 24 age-matched normal subjects underwent high-definition raster scanning using spectral-domain optical coherence tomography with frame enhancement software. Patients with diabetes were classified into 3 groups: 11 patients with mild or moderate nonproliferative diabetic retinopathy and no macular edema, 18 patients with nonproliferative diabetic retinopathy and diabetic macular edema, and 20 patients with treated proliferative diabetic retinopathy and no diabetic macular edema (treated proliferative diabetic retinopathy). Choroidal thickness was measured from the posterior edge of the retinal pigment epithelium to the choroid/sclera junction at 500-[mu]m intervals up to 2,500 [mu]m temporal and nasal to the fovea.
Results: Reliable measurements of choroidal thickness were obtainable in 75.3% of eyes examined. Mean choroidal thickness showed a pattern of thinnest choroid nasally, thickening in the subfoveal region, and thinning again temporally in normal subjects and patients with diabetes. Mean subfoveal choroidal thickness was thinner in patients with diabetic macular edema (63.3 [mu]m, 27.2%, P < 0.05) or treated proliferative diabetic retinopathy (69.6 [mu]m, 30.0%, P < 0.01), compared with normal subjects. There was no difference between nonproliferative diabetic retinopathy and normal subjects.
Conclusion: Choroidal thickness is altered in diabetes and may be related to the severity of retinopathy. Presence of diabetic macular edema is associated with a significant decrease in the choroidal thickness. |
first_indexed | 2024-09-23T10:03:10Z |
format | Article |
id | mit-1721.1/86410 |
institution | Massachusetts Institute of Technology |
language | en_US |
last_indexed | 2024-09-23T10:03:10Z |
publishDate | 2014 |
publisher | Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins |
record_format | dspace |
spelling | mit-1721.1/864102022-09-26T15:23:30Z CHOROIDAL THICKNESS IN PATIENTS WITH DIABETIC RETINOPATHY ANALYZED BY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY Regatieri, Caio V. Branchini, Lauren Carmody, Jill Fujimoto, James G. Duker, Jay S. Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science Massachusetts Institute of Technology. Research Laboratory of Electronics Fujimoto, James G. Purpose: This study was designed to examine choroidal thickness in patients with diabetes using spectral-domain optical coherence tomography. Methods: Forty-nine patients (49 eyes) with diabetes and 24 age-matched normal subjects underwent high-definition raster scanning using spectral-domain optical coherence tomography with frame enhancement software. Patients with diabetes were classified into 3 groups: 11 patients with mild or moderate nonproliferative diabetic retinopathy and no macular edema, 18 patients with nonproliferative diabetic retinopathy and diabetic macular edema, and 20 patients with treated proliferative diabetic retinopathy and no diabetic macular edema (treated proliferative diabetic retinopathy). Choroidal thickness was measured from the posterior edge of the retinal pigment epithelium to the choroid/sclera junction at 500-[mu]m intervals up to 2,500 [mu]m temporal and nasal to the fovea. Results: Reliable measurements of choroidal thickness were obtainable in 75.3% of eyes examined. Mean choroidal thickness showed a pattern of thinnest choroid nasally, thickening in the subfoveal region, and thinning again temporally in normal subjects and patients with diabetes. Mean subfoveal choroidal thickness was thinner in patients with diabetic macular edema (63.3 [mu]m, 27.2%, P < 0.05) or treated proliferative diabetic retinopathy (69.6 [mu]m, 30.0%, P < 0.01), compared with normal subjects. There was no difference between nonproliferative diabetic retinopathy and normal subjects. Conclusion: Choroidal thickness is altered in diabetes and may be related to the severity of retinopathy. Presence of diabetic macular edema is associated with a significant decrease in the choroidal thickness. National Institutes of Health (U.S.) (Contract RO1-EY11289-23) National Institutes of Health (U.S.) (Contract R01-EY13178-07) National Institutes of Health (U.S.) (Contract R01-EY013516-07) United States. Air Force Office of Scientific Research (Grant FA9550-07-1-0101) United States. Air Force Office of Scientific Research (Grant FA9550-07-1-0014) 2014-05-05T17:14:08Z 2014-05-05T17:14:08Z 2012-03 Article http://purl.org/eprint/type/JournalArticle 0275-004X http://hdl.handle.net/1721.1/86410 Regatieri, Caio V., Lauren Branchini, Jill Carmody, James G. Fujimoto, and Jay S. Duker. “CHOROIDAL THICKNESS IN PATIENTS WITH DIABETIC RETINOPATHY ANALYZED BY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY.” Retina (February 2012): 1. https://orcid.org/0000-0002-0828-4357 en_US http://dx.doi.org/10.1097/iae.0b013e31822f5678 Retina Creative Commons Attribution-Noncommercial-Share Alike http://creativecommons.org/licenses/by-nc-sa/4.0/ application/pdf Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins PMC |
spellingShingle | Regatieri, Caio V. Branchini, Lauren Carmody, Jill Fujimoto, James G. Duker, Jay S. CHOROIDAL THICKNESS IN PATIENTS WITH DIABETIC RETINOPATHY ANALYZED BY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY |
title | CHOROIDAL THICKNESS IN PATIENTS WITH DIABETIC RETINOPATHY ANALYZED BY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY |
title_full | CHOROIDAL THICKNESS IN PATIENTS WITH DIABETIC RETINOPATHY ANALYZED BY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY |
title_fullStr | CHOROIDAL THICKNESS IN PATIENTS WITH DIABETIC RETINOPATHY ANALYZED BY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY |
title_full_unstemmed | CHOROIDAL THICKNESS IN PATIENTS WITH DIABETIC RETINOPATHY ANALYZED BY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY |
title_short | CHOROIDAL THICKNESS IN PATIENTS WITH DIABETIC RETINOPATHY ANALYZED BY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY |
title_sort | choroidal thickness in patients with diabetic retinopathy analyzed by spectral domain optical coherence tomography |
url | http://hdl.handle.net/1721.1/86410 https://orcid.org/0000-0002-0828-4357 |
work_keys_str_mv | AT regatiericaiov choroidalthicknessinpatientswithdiabeticretinopathyanalyzedbyspectraldomainopticalcoherencetomography AT branchinilauren choroidalthicknessinpatientswithdiabeticretinopathyanalyzedbyspectraldomainopticalcoherencetomography AT carmodyjill choroidalthicknessinpatientswithdiabeticretinopathyanalyzedbyspectraldomainopticalcoherencetomography AT fujimotojamesg choroidalthicknessinpatientswithdiabeticretinopathyanalyzedbyspectraldomainopticalcoherencetomography AT dukerjays choroidalthicknessinpatientswithdiabeticretinopathyanalyzedbyspectraldomainopticalcoherencetomography |